PAIN-LESS: Understanding and Alleviating Pain for Cancer Patients in Academic and Community Hospitals

Cancer Clinical Trial

Official title:

PAIN-LESS: Understanding and Alleviating Pain for Cancer Patients in Academic and Community Hospitals

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02559375
• Other study ID #: UPCC 26914
• Status: Completed
• Start date: September 2014
• Est. completion date: September 30, 2015

Study information

• Verified date: July 2019
• Source: Abramson Cancer Center of the University of Pennsylvania
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study will increase knowledge of patient preferences for pain treatments, and improve the ability to meet patients pain management needs. This study will assess patient attitudes towards underutilized treatments and identify technologies to increase awareness of such treatments. This study also demonstrate the feasibility of using the Penn Cancer Network in future clinical and cancer control research and better understand how to effectively raise patients awareness of supportive cancer services.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 466
• Est. completion date: September 30, 2015
• Est. primary completion date: September 30, 2015
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age 18 or older; Have a primary diagnosis of cancer;

• Have a Karnofsky functional score of 60 or greater (i.e. ambulatory);

• Understand written English;

• Verbally indicate to the RA/RN that they feel physically well enough to complete a survey at the time of approach;

• Report experiencing nonzero pain (on a scale of 0-10) in the last seven days

Exclusion Criteria:

• An inability to understand the requirements of the survey

Related Conditions & MeSH terms

• Cancer

Intervention

Other:
• Survey

Locations

Country	Name	City	State
United States	Abramson Cancer Center of the University of Pennsylvania	Philadelphia	Pennsylvania

Sponsors (1)

Lead Sponsor	Collaborator
Abramson Cancer Center of the University of Pennsylvania

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of subjects providing completed surveys		1 year